Global Endoscope Reprocessing Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
High-Level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Drying, Storage & Transport Systems, Endoscope Tracking Systems, and OthersBy End Users;
Hospitals, Ambulatory Surgery Centers, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Endoscope Reprocessing Market Overview
Endoscope Reprocessing Market (USD Million)
Endoscope Reprocessing Market was valued at USD 1,972.68 million in the year 2024. The size of this market is expected to increase to USD 3,095.87 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.7%.
Global Endoscope Reprocessing Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 6.7 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 6.7 % |
Market Size (2024) | USD 1,972.68 Million |
Market Size (2031) | USD 3,095.87 Million |
Market Concentration | Medium |
Report Pages | 321 |
Major Players
- Olympus
- Wassenburg Medical
- Custom Ultrasonics
- Steris
- Steelco
- Getinge
- Endo-Technik W. Griesat
- BES Decon
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Endoscope Reprocessing Market
Fragmented - Highly competitive market without dominant players
The Endoscope Reprocessing Market is gaining traction due to increased focus on infection control and the widespread use of endoscopic procedures. Healthcare providers are emphasizing regulatory compliance, leading to higher demand for advanced reprocessing systems. An estimated 68% of endoscopy units have adopted automated systems to improve operational hygiene and prevent cross-contamination.
Technological Advancements
Innovations such as residue-free chemicals and compatibility with diverse endoscopes are enhancing the reliability of reprocessing. About 61% of practitioners have noted improvements in workflow and safety. Systems equipped with digital tracking and verification features are also emerging as essential tools for efficient and error-free procedures.
Regulatory Influence
Stricter enforcement of standards has prompted healthcare institutions to prioritize regulatory-aligned equipment. Reports suggest 72% of accredited centers are actively upgrading their reprocessing workflows. The push toward verified and traceable systems is helping facilities meet inspection readiness and reduce non-compliance risks.
Future Outlook
The market is expected to see continued momentum as infection prevention strategies remain central to healthcare delivery. Roughly 64% of decision-makers are planning upgrades to their reprocessing capabilities. As a result, there is strong growth potential driven by the dual goals of patient safety and procedural efficiency.
Endoscope Reprocessing Market Recent Developments
-
In December 2024, HOYA Corporation finalized the acquisition of all outstanding shares of Plasmabiotics SAS, securing full ownership of its PlasmaTYPHOON and AquaTYPHOON systems to bolster its automated endoscope reprocessing offerings.
-
In September 2023, Olympus completed the spin‑off of its microscopy and scientific imaging division into the independent Evident Corporation, sharpening its strategic focus on endoscope and reprocessing system innovation.
Endoscope Reprocessing Market Segment Analysis
In this report, the Endoscope Reprocessing Market has been segmented by Product, End Users, and Geography.
Endoscope Reprocessing Market, Segmentation by Product
The Endoscope Reprocessing Market has been segmented by Product into High-Level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Drying, Storage, & Transport Systems, Endoscope Tracking Systems, and Others.
High-Level Disinfectants & Test Strips
High-level disinfectants and test strips dominate the endoscope reprocessing market, accounting for approximately 35% of total revenue. These products are essential for effective reprocessing, ensuring pathogen elimination and maintaining infection control standards in healthcare facilities.
Detergents & Wipes
Detergents and wipes represent about 20% of the market, used for pre-cleaning endoscopes and removing organic debris. The rising focus on comprehensive cleaning protocols supports growth in this segment.
Automated Endoscope Reprocessors
Automated endoscope reprocessors (AERs) hold approximately 25% of total revenue, providing standardized and efficient reprocessing of endoscopes with minimal human intervention. The demand for automation and compliance with regulatory guidelines fuels growth.
Endoscope Drying, Storage, & Transport Systems
This segment contributes around 10% of the market, offering solutions for safe storage, effective drying, and secure transport of reprocessed endoscopes to reduce contamination risk.
Endoscope Tracking Systems
Endoscope tracking systems represent about 5% of total revenue, enabling real-time monitoring and documentation of endoscope reprocessing cycles. These systems support compliance and traceability in healthcare facilities.
Others
The 'Others' category accounts for nearly 5% of the market, including specialty cleaning accessories, enzymatic cleaners, and innovative disinfection technologies designed to enhance endoscope reprocessing outcomes.
Endoscope Reprocessing Market, Segmentation by End Users
The Endoscope Reprocessing Market has been segmented by End Users into Hospitals, Ambulatory Surgery Centers, and Others.
Hospitals
Hospitals dominate the endoscope reprocessing market, accounting for approximately 60% of total revenue. They require robust reprocessing protocols to ensure patient safety and infection control for a high volume of endoscopic procedures. The emphasis on compliance and regulatory standards supports this segment’s growth.
Ambulatory Surgery Centers
Ambulatory surgery centers represent about 30% of the market, focusing on cost-effective reprocessing solutions and efficient turnaround times. The increasing number of minimally invasive procedures in these settings drives demand for endoscope reprocessing systems.
Others
The 'Others' category contributes nearly 10% of total revenue, including specialty clinics and diagnostic centers that perform endoscopic procedures and require reprocessing solutions tailored to their specific needs.
Endoscope Reprocessing Market, Segmentation by Geography
In this report, the Endoscope Reprocessing Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Endoscope Reprocessing Market Share (%), by Geographical Region
North America
North America leads the endoscope reprocessing market, accounting for approximately 40% of total revenue. This dominance is driven by stringent infection control regulations, widespread adoption of advanced reprocessing technologies, and the presence of major market players ensuring high-quality reprocessing solutions.
Europe
Europe holds about 25% of the market, supported by a strong focus on patient safety, increasing endoscopy procedure volumes, and rising adoption of automated reprocessing systems. Key contributors include Germany, the UK, and France.
Asia Pacific
Asia Pacific represents nearly 20% of total revenue, fueled by expanding healthcare infrastructure, rising healthcare awareness, and increasing investments in endoscopy services across countries like China, Japan, and India.
Middle East and Africa
The Middle East and Africa contribute about 8% of the market, with growth driven by improving healthcare delivery systems, increasing focus on infection prevention, and expanding healthcare investments in countries like Saudi Arabia, South Africa, and the UAE.
Latin America
Latin America accounts for nearly 7% of total revenue, led by Brazil, Mexico, and Argentina. The region benefits from rising healthcare expenditure, growing adoption of reprocessing technologies, and increasing awareness of endoscope hygiene.
Endoscope Reprocessing Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Endoscope Reprocessing Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Stringent Regulatory Guidelines for Reprocessing Endoscopes
- Growing Focus on Infection Control Measures
- Technological Advancements in Endoscope Reprocessing Systems
-
Rising Awareness Regarding the Importance of Reprocessing Endoscopes - The growing awareness among healthcare professionals and institutions about the critical importance of reprocessing endoscopes is a key factor driving the endoscope reprocessing market. With endoscopes being reusable medical devices that come into direct contact with internal body structures, there is a heightened understanding that thorough cleaning, disinfection, and sterilization are essential to patient safety. This awareness has been fueled by guidelines from global regulatory bodies and infection control agencies.
Educational campaigns, hospital accreditation standards, and published reports on endoscope-related infection outbreaks have all contributed to a more informed medical community. Healthcare providers are increasingly recognizing that improper or inconsistent reprocessing can lead to severe healthcare-associated infections (HAIs), which pose risks to patient health and institutional reputation. As a result, investments in standardized reprocessing equipment and staff training are on the rise.
The rise in minimally invasive procedures, which heavily rely on endoscopy, has further underscored the need for safe and repeatable reprocessing protocols. This has led to increased demand for automated reprocessors, enzymatic cleaners, and disinfectants that can meet regulatory and clinical expectations. Hospitals and clinics are now integrating reprocessing best practices into their infection control frameworks to minimize liabilities and enhance care quality.
As awareness continues to rise through audits, research, and global safety initiatives, the need for advanced, validated reprocessing systems will continue to grow. This shift in clinical mindset is expected to sustain long-term demand for endoscope reprocessing products and services worldwide.
Restraints
- Concerns Regarding Effectiveness of Reprocessing Techniques
- Lack of Skilled Personnel for Proper Endoscope Reprocessing
- Challenges in Standardizing Reprocessing Protocols Across Healthcare Facilities
-
Risk of Cross-Contamination Despite Reprocessing Efforts - Despite advancements in endoscope reprocessing methods, the risk of cross-contamination remains a significant concern, acting as a major restraint in the market. Multiple studies and incident reports have highlighted that even after standard reprocessing protocols are followed, residual organic material or microbial contamination can persist, potentially exposing patients to harmful infections.
This risk is heightened by the complex design of endoscopes, particularly those with narrow lumens and intricate channels, which can be difficult to clean thoroughly. Even minor lapses in protocol or inconsistencies in manual cleaning steps can lead to contamination. These limitations cast doubt on the absolute reliability of reprocessing and have led to hesitation in widespread adoption in some healthcare settings.
Additionally, incidents of infection outbreaks linked to reprocessed endoscopes have attracted negative media coverage and regulatory scrutiny. These events undermine confidence in existing systems and increase pressure on healthcare providers to invest in supplemental or alternative safety technologies, which may not always be economically feasible, particularly for small or rural facilities.
Unless there are significant innovations in device design, reprocessing technology, or quality assurance methods, the persistent concern over contamination risks will continue to hinder the growth of the market. Ensuring consistent and reliable outcomes remains a key challenge for manufacturers and end users alike.
Opportunities
- Development of Automated Endoscope Reprocessing Systems
- Adoption of Single-Use Endoscopes and Reprocessing Accessories
- Increasing Investments in Research and Development of Advanced Reprocessing Technologies
-
Collaboration Between Manufacturers and Healthcare - Strategic collaboration between endoscope reprocessing equipment manufacturers and healthcare providers offers a major opportunity for growth in this market. These partnerships enable the development of customized, user-centered solutions that address the specific challenges faced in hospital and clinical reprocessing workflows. By working closely with medical staff, manufacturers can design more ergonomic, efficient, and compliant systems tailored to real-world demands.
Collaborations also support co-development initiatives focused on enhancing infection control efficacy. Hospitals benefit from access to advanced prototypes, pilot programs, and technical training, while manufacturers gain valuable feedback for refining their products. These engagements help drive continuous innovation in automated reprocessors, chemical formulations, and digital tracking systems that improve safety and compliance.
Partnerships with academic institutions and research centers further support evidence-based product development. Joint clinical studies and white papers help validate the effectiveness of new technologies, strengthening market confidence and aiding regulatory approval. Moreover, such collaborations can expand awareness and facilitate knowledge-sharing within the broader medical community.
Endoscope Reprocessing Market Competitive Landscape Analysis
Key players in Endoscope Reprocessing Market include :
- Cantel Medical (US)
- Advanced Sterilization Products (ASP) (US)
- Olympus Corporation (Japan)
- Ecolab (US)
- STERIS plc (Ireland)
- Getinge AB (Sweden)
- Wassenburg Medical (Netherlands)
- CONMED Corporation (US)
- Belimed AG (Switzerland)
- Endo‑Technik W. Griesat (Germany)
- Custom Ultrasonics (US)
- Steelco S.p.A. (Italy)
- BES Healthcare Ltd (UK)
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Development
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Endoscope Reprocessing Market Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Stringent Regulatory Guidelines for Reprocessing Endoscopes
- Growing Focus on Infection Control Measures
- Technological Advancements in Endoscope Reprocessing Systems
- Rising Awareness Regarding the Importance of Reprocessing Endoscopes
- Restraints
- Concerns Regarding Effectiveness of Reprocessing Techniques
- Lack of Skilled Personnel for Proper Endoscope Reprocessing
- Challenges in Standardizing Reprocessing Protocols Across Healthcare Facilities
- Risk of Cross-Contamination Despite Reprocessing Efforts
- Opportunities
- Development of Automated Endoscope Reprocessing Systems
- Adoption of Single-Use Endoscopes and Reprocessing Accessories
- Increasing Investments in Research and Development of Advanced Reprocessing Technologies
- Collaboration Between Manufacturers and Healthcare
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Endoscope Reprocessing Market Market, By Product, 2021 - 2031 (USD Million)
- High-Level Disinfectants & Test Strips
- Detergents & Wipes
- Automated Endoscope Reprocessors
- Endoscope Drying
- Storage & Transport Systems
- Endoscope Tracking Systems
- Others
- Endoscope Reprocessing Market Market, By End Users, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgery Centers
- Others
- Endoscope Reprocessing Market Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Endoscope Reprocessing Market Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Cantel Medical (US)
- Advanced Sterilization Products (ASP) (US)
- Olympus Corporation (Japan)
- Ecolab (US)
- STERIS plc (Ireland)
- Getinge AB (Sweden)
- Wassenburg Medical (Netherlands)
- CONMED Corporation (US)
- Belimed AG (Switzerland)
- Endo‑Technik W. Griesat (Germany)
- Custom Ultrasonics (US)
- Steelco S.p.A. (Italy)
- BES Healthcare Ltd (UK)
- Company Profiles
- Analyst Views
- Future Outlook of the Market